The duration of hospitalization was also significantly longer among the patients who experienced severe neutropenia or were treated with therapeutic G-CSF than the patients who did not experience severe neutropenia or were not treated with therapeutic G-CSF. The gene discussed is CSF3; the disease is neutropenia.